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Abstract
Background European Society of Cardiology (ESC)
guidelines recommend same-day transfer to a per-
cutaneous coronary intervention (PCI) centre for an-
giography in high-risk (ESC-HR) patients with non-
ST-elevation acute coronary syndrome (NSTE-ACS).
We describe the treatment patterns of NSTE-ACS pa-
tients presenting at non-PCI centres and evaluate the
logistical consequences of adopting same-day trans-
fer.
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Methods From August 2016 until January 2017, all
consecutive NSTE-ACS patients presenting at 23 non-
PCI centres in the Netherlands were recorded. We
built an online case report form in collaboration with
the National Cardiovascular Database Registry to col-
lect information on risk stratification by the attending
physician, timing and location of angiography, and
treatment.
Results We included 871 patients (mean age 69.1±
12.8). 55.8% were considered ESC-HR. Overall, an-
What’s new
 The 2015 ESC NSTE-ACS guidelines recommend
same-day transfer (<24h) to a PCI centre for an-
giography in NSTE-ACS patients with elevated
troponin levels.
 The majority of Dutch non-PCI centres perform
angiography in NSTE-ACS patients, contrary to
the guidelines.
 Consequences of adopting same-day transfer in
the Netherlands remain unclear.
 In this registry half of the patients present-
ing at non-PCI centres undergo angiography at
a non-PCI centre. Same-day transfer occurred
in one-quarter of the patients.
 Non-selective adoption would increase same-
day transfers of NSTE-ACS patients who undergo
PCI, however, equally increases transfers to PCI
centres of patients who are eventually medically
treated.
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giography at non-PCI centres was 55.1% and revas-
cularisation was 54.1%. Among ESC-HR patients, an-
giography at non-PCI centres was 51.4% and revas-
cularisation was 54.9%. Angiography <24h was 55.6%
in patients with angiography at a non-PCI centre and
74.3% in patients with angiography at a PCI-centre.
Assuming patients would receive similar treatment,
adoption of same-day transfer would increase trans-
fers of ESC-HR patients who undergo PCI (44.3%), but
also increases transfers of medically treated patients
(36.2%) and patients awaiting coronary bypass artery
grafting (9.1%).
Conclusions In this registry of NSTE-ACS patients at
non-PCI centres, the majority of ESC-HR patients un-
derwent angiography at a non-PCI centre. Same-day
transfer occurred in one-quarter of the ESC-HR pa-
tients, despite guideline recommendation. Nonselec-
tive adoption of same-day transfer to a PCI centre
would increase transfers of ESC-HR patients who un-
dergo PCI, however, equally increases transfers of pa-
tients who are medically treated.
Keywords Non-ST-elevation acute coronary syn-
drome · coronary angiography · PCI · same-day trans-
fer
Introduction
Non-ST-elevation acute coronary syndrome (NSTE-
ACS) encompasses a clinical syndrome caused by su-
perimposed thrombus formation due to intracoronary
plaque rupture or erosion [1]. Coronary angiography
is used to confirm obstructive coronary artery disease
and select treatment with percutaneous coronary
intervention (PCI), coronary bypass artery grafting
(CABG), or medical therapy alone [1]. The European
Society of Cardiology (ESC) recommends immedi-
ate angiography (<2h) in patients at very high risk for
mortality (ESC-VHR) (e.g. recurrent refractory angina,
life-threatening arrhythmia or cardiogenic shock and
haemodynamic instability) [1]. Early angiography is
recommended in high-risk patients (ESC-HR) pre-
senting with a rise or fall in high-sensitivity cardiac
troponin (hs-cTn), or dynamic ST- or T-wave changes,
or a Global Registry of Acute Coronary Events (GRACE)
risk score >140 points. In intermediate-risk patients
(ESC-IR) the guidelines advise to undergo angiogra-
phy within 72h In low-risk patients (ESC-LR), a non-
invasive ischaemia detection test is recommended.
Various randomised trials support the use of an
early invasive strategy with angiography within 24h
[2, 3]. However, other studies could not demonstrate
a benefit of an early invasive strategy versus a more
ischemia-driven selective invasive strategy, includ-
ing patients with elevated cardiac troponin levels
[4]. Moreover, recent meta-analyses of contemporary
randomised trials could not establish an association
between an early invasive strategy and hard clinical
outcomes, compared with a delayed strategy [5, 6].
Compared with the 2011 guidelines, the 2015 NSTE-
ACS guidelines put more emphasis on same-day
transfer to a PCI centre in patients with at least one
high-risk criterion (e.g. elevated hs-cTn [2015 NSTE-
ACS guidelines, Fig. 6]) [1, 7]. Both the 2011 and 2015
guidelines recommend ‘timely transfer for patients
admitted to hospitals without on-site catheterisation
facilities’ [1]. However, the guidelines do not specif-
ically comment on ESC-HR patients presenting at
non-PCI centres with on-site catheterisation facilities.
In the Netherlands, the majority of non-PCI centres
are equipped with chest pain units, cardiac care units,
and catheterisation laboratories where NSTE-ACS pa-
tients often undergo angiography. Angiographic re-
sults are discussed in a Heart Team and, if indicated,
patients are referred to an interventional centre for
PCI or CABG procedures.
The members if the ACS Working Group of the
Netherlands Society of Cardiology (NVVC) remain
concerned over the adoption of same-day transfer to
PCI centres. They suggested that adoption of same-
day transfer may increase transfers of patients with
hs-cTn elevation due to type 2 myocardial infarction
(MI) or other cardiac and non-cardiac aetiologies
[8]. In addition, the possible logistical consequences
of adopting same-day transfer for ambulance ser-
vices and PCI and non-PCI centres remain unclear.
The objective of this study was to describe the cur-
rent treatment patterns (not the outcomes) of NSTE-
ACS patients presenting at non-PCI centres in the
Netherlands and evaluate the possible logistical con-
sequences of adopting same-day transfer in clinical
practice.
Methods
Study population and data collection
From August 22th, 2016, until January 31th, 2017, all
consecutive patients with a diagnosis or suspicion of
NSTE-ACS who presented to 1 of 23 voluntarily par-
ticipating non-PCI centres in the Netherlands were
included (participating hospitals listed below). All
hospitals were equippedwith catheterisation facilities.
Hospitals prospectively recorded in an online form
baseline characteristics, medical history, ESC risk cat-
egory stratified by the attending physicians, Heart
Team discussion, and timing of invasive angiography
and revascularisation. Cardiologists from the Dutch
non-ST-elevation myocardial infarction (NSTEMI)-
ACS project group developed and approved this con-
cise form. According to Dutch law no informed
consent had to be obtained for this study.
Data management
The online form was developed and managed by Re-
ports BV (Almere, the Netherlands) and National Car-
diovascular Database Registry (NCDR) (Utrecht, the
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Netherlands). NCDR is an independent Dutch registry
with experience in ACS registries [9]. All data were
stored anonymously with an encrypted identification
number. A trusted third party (Zorg TTP, Houten, the
Netherlands) managed the decryption key.
Definitions
NSTE-ACS was defined as acute angina (or atypical
presentation suspected for NSTE-ACS) >20min at rest
in presence of normal ECG findings or ECG patterns
associated with NSTE-ACS (ST-segment depression,
transient ST-segment elevation, and T-wave changes).
The attending physician used ESC NSTE-ACS risk cri-
teria to stratify patients into risk categories [1]. Time
to angiography or revascularisation was defined as
time from admission to procedure.
Statistical analysis
Normally distributed continuous variables were rep-
resented by mean and standard deviation. Non-nor-
mally distributed variables are shown using median
and interquartile range (IQR). Continuous variables
we compared with the unpaired T test or Mann-Whit-
ney U test, as appropriate and categorical variables
with the χ2 test. A p-value of <0.05 was considered
statistically significant. All analyses were performed
using SPSS version 24.0 (SPSS Inc, Chicago, IL, USA).
Results
Demographics, risk factors, and medical history
A total of 871 patients (Tab. 1) from 23 non-PCI
centres were included in this registry (Fig. 1). The
number of patients per centre ranged between 1 and
86 cases (1 centre recorded 1 patient, all other centres
recorded ≥18 patients). The mean age was 69.1 (±12.8)
and 36.9% of patients were female. A definite NSTE-
ACS diagnosis at admission according to the attend-
ing physician was reported in 86.1% of patients. All
23 centres performed on-site coronary angiography.
ESC risk stratification and angiography
The majority of patients (55.8%) were categorised as
ESC-HR (Fig. 2). A rise or fall of hs-cTn was the
most common criterion in ESC-HR patients (80.0%)
(Tab. 2). Overall, 84.7% underwent angiography dur-
ing hospitalisation (Tab. 3). The median time to an-
giography was 24h (IQR: 12–48h). Overall, the ma-
jority of patients (55.1%) underwent angiography at
a non-PCI centre, followed by 24.9% of patients who
had initial angiography at a PCI centre. Some patients
(4.7%) underwent angiography at a non-PCI centre
followed by a second angiography at a PCI centre
(for additional assessment usually with PCI performed
subsequently). The number of patients undergoing
Table 1 Demographics and clinical characteristics
NSTE-ACS patients
(n= 871)
Age 69.1± 12.8
Female 321/871 (36.9)
Definite NSTE-ACS diagnosis 750/871 (86.1)
Admission during weekdays 652/871 (74.9)
Atrial fibrillation 87/871 (10.0)
Diabetes mellitus 156/871 (17.9)
Heart failure 34/871 (3.9)
Renal insufficiency 131/871 (15.0)
Previous AMI 137/871 (15.7)
Previous CABG 75/871 (8.6)
Previous CVA 59/871 (6.8)
Previous PAD 55/871 (6.3)
Previous PCI 170/871 (19.5)
Values are number of cases (%) or mean± standard deviation.
Renal insufficiency is defined as glomerular filtration rate <60ml/min/1.732.
NSTE-ACS non ST-elevation acute coronary syndrome, AMI acute myocar-
dial infarction, CABG coronary bypass grafting, CVA cerebrovascular
accident, PAD peripheral artery disease, PCI percutaneous coronary inter-
vention
Fig. 1 A map of the Netherlands with the participating 23
non-PCI centres and all 30 PCI centres
angiography per risk category was as follows: 85.7%
in ESC-VHR, 81.3% in ESC-HR, 89.5% of ESC-IR pa-
tients (Tab. 3). Overall, 90.7% of patients underwent
angiography <72h Angiography was performed within
the time frame recommended by the ESC in 57.5% of
ESC-VHR (<2h), 60.8% of ESC-HR (<24h), in 91.8% of
ESC-IR (<72h) patients.
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Table 2 ESC risk stratification
NSTE-ACS patients
(n= 871)
Very-high-risk criteria (n= 56)
Haemodynamic instability or cardiogenic shock 1/56 (1.8)
Recurrent or ongoing chest pain refractory to medical
treatment
31/56 (55.4)
Life-threatening arrhythmias or cardiac arrest 4/56 (7.1)
Mechanical complications of MI 0/56 (0.0)
Acute heart failure 13/56 (23.2)
Recurrent or dynamic ST-T wave changes 14/56 (25.0)
High-risk criteria (n= 486)
Rise or fall in cardiac troponin compatible with MI 389/486 (80.0)
Dynamic ST- or T-wave changes (symptomatic or
silent)
118/486 (24.3)
GRACE score >140 187/486 (38.5)
Intermediate-risk criteria (n= 256)
Diabetes mellitus 48/256 (18.8)
Renal insufficiency 42/256 (16.4)
LVEF <40% or congestive heart failure 8/256 (3.1)
Early post-infarction angina 6/256 (2.3)
Prior PCI 36/256 (14.1)
Prior CABG 16/256 (6.3)
GRACE risk score >109 and <140 193/256 (75.4)
Low-risk score/none of the above (n= 73)
Values are number of cases (%)
ESC European Society of Cardiology, NSTE-ACS non ST-elevation acute
coronary syndrome, MI myocardial infarction, LVEF left ventricular ejection
fraction, PCI percutaneous coronary intervention, CABG coronary bypass
grafting
Fig. 2 Proportion of ESC
risk categories in all 871
NSTE-ACS presentations
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Treatment
In total, 54.1% of patients underwent revascularisa-
tion (43.2% PCI and 10.9% CABG) and 35.7% were
treated with medical therapy (Tab. 3). Treatment was
not recorded for 10.2% of patients. Revascularisation
was performed in 54.9% of ESC-HR patients. Overall,
28.3% of patients who underwent angiography were
treated with medical therapy.
Angiography at a non-PCI centre (non-transferred)
versus angiography at a PCI centre (transferred)
Baseline characteristics of patients who underwent
angiography at a non-PCI centre (non-transferred) or
at a PCI centre (transferred) were mostly similar, how-
ever, non-transferred patients were older (67.4± 11.3
vs. 65.1± 12.7, p=0.02). The distribution of risk cate-
gories was markedly differed among non-transferred
and transferred patients, except for ESC-HR patients
(Fig. 3). Median time to angiography was shorter in
transferred patients (10h, IQR: 2–24) compared with
patients who underwent angiography at a non-PCI
centre (24h, IQR: 16.8–48). Transferred patients were
less often discussed by the Heart Team (57.9% vs.
26.7%, p< 0.001). Revascularisation was 58.3% in non-
transferred patients and 71.0% in transferred patients
(p< 0.001).
High-risk patients
All 23 non-PCI centres admitted ESC-HR patients,
of which 22 centres (95.7%) performed on-site an-
giography in these patients. Non-transferred ESC-
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Table 3 Timing of coronary angiography and revascularisation in ESC risk groups
NSTE-ACS patients (n= 871)
Overall Very high High Intermediate
(n= 871) (n= 56) (n= 486) (n= 256)
Coronary angiography
Angiography 738/871 (84.7) 48/56 (85.7) 395/486 (81.3) 229/256 (89.5)
Angiography at non-PCI centre 480/871 (55.1) 6/56 (10.7) 250/486 (51.4) 166/256 (64.8)
Angiography at PCI centre 217/871 (24.9) 39/56 (69.9) 123/486 (25.3) 48/256 (18.8)
Angiography at non-PCI and PCI centrea 41/871 (4.7) 3/56 (5.4) 22/486 (4.5) 15/256 (5.9)
No angiography 102/871 (11.7) 8/56 (14.3) 72/486 (14.8) 16/256 (6.3)
Unknown 31/871 (3.6) 0/56 (0.0) 19/486 (3.9) 11/256 (4.3)
Timing of coronary angiography
Angiography <2h 71/636 (11.2) 23/40 (57.5) 34/337 (10.1) 11/196 (5.6)
Angiography 3–24h 299/636 (47.0) 8/40 (20.0) 171/337 (50.7) 90/196 (45.9)
Angiography <24h 370/636 (58.2) 31/40 (77.5) 205/337 (60.8) 101/196 (51.5)
Angiography 25–72h 207/636 (32.5) 5/40 (12.5) 96/337 (28.5) 79/196 (40.3)
Angiography <72h 557/636 (90.7) 36/40 (90.0) 301/337 (89.3) 180/196 (91.8)
Heart team
Discussed by Heart Team 366/871 (42.0) 12/56 (21.4) 200/486 (41.2) 123/256 (48.0)
Treatment
Revascularisation 471/871 (54.1) 34/56 (60.7) 267/486 (54.9) 142/256 (55.5)
PCI 376/871 (43.2) 30/56 (53.6) 215/486 (44.2) 111/256 (43.4)
CABG 95/871 (10.9) 4//56 (7.1) 52/486 (10.7) 31/256 (12.1)
Medical therapy 311/871 (35.7) 15/56 (26.8) 173/486 (35.6) 87/256 (34.0)
Unknown 89/871 (10.2) 7/56 (12.5) 46/486 (9.5) 27/256 (10.5)
Treatment after angiography
Revascularisation 471/738 (63.8) 34/48 (70.8) 267/486 (67.6) 142/229 (62.0)
PCI 376/738 (50.9) 30/48 (62.5) 215/486 (54.4) 111/229 (48.5)
CABG 95/738 (12.9) 4/48 (8.3) 52/486 (13.2) 31/229 (13.5)
Medical therapy 209/738 (28.3) 10/48 (20.8) 104/486 (26.3) 64/229 (27.9)
Unknown 58/738 (7.9) 4/48 (8.3) 24/486 (6.1) 23/229 (10.0)
Time indicators (hours)
Time to coronary angiography 24.0 (12.0–48.0) 636 pts 2.0 (1.0–24.0) 40 pts 24.0 (10–48.0) 337 pts 24.0 (16.0–48.0)
196 pts
Time to PCI 65.0 (21.8–120.0) 318 pts 2.0 (1.0–33.0) 24 pts 72 (24.0–120.0) 182 pts 66.0 (24.0–120.0)
92 pts
Time to CABG 216.5 (163.8–322.5) 24 pts 217.0 (229.5–) 2 pts 216 (169.5–381.0) 13 pts 175.0 (78.5–298.8) 8 pts
Values are number of cases (%) or median with interquartile range; time in hours
All patients were first admitted to a non-PCI centre. Coronary angiography at PCI centre indicates transfer from a non-PCI centre to a PCI centre with initial
angiography at the PCI centre
ESC European Society of Cardiology, NSTE-ACS non ST-elevation acute coronary syndrome, PCI percutaneous coronary intervention, CABG coronary bypass
grafting, pts patients
ainitial angiography at a non-PCI centre with additional angiography at a PCI centre for additional assessment (e. g. additional angiographic assessment,
sometimes followed by intracoronary fractional flow reserves and/or coronary flow reserve measurements)
HR patients were older (68.7 (±11.7) vs. 64.7 (±13.1),
p= 0.003), without other baseline differences. Angiog-
raphy <24h was more common in transferred ESC-
HR patients (74.3% vs. 55.6%, p=0.004). Notably,
angiography <2h was higher among transferred ESC-
HR patients (23.0% vs. 6.2%, p<0.001) and angiogra-
phy <3–24h was similar (transferred: 51.3% vs. non-
transferred: 49.4%, p= 0.77). Heart Team discussion
was more common in non-transferred ESC-HR pa-
tients (58.4% vs. 30.9%). Revascularisation was higher
in transferred ESC-HR patients (74.8% vs. 62.0%,
p= 0.002).
Possible consequences of adopting same-day
transfer to a PCI centre
Angiography and revascularisation status was known
in 91.2% of ESC-HR patients (Fig. 4). In our current
observation, 14.8% of ESC-HR did not undergo an-
giography and 21.4% were medically treated after an-
giography. Of the patients who underwent CABG, the
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Fig. 3 Differences in per-
centage of each ESC risk
category displayed for pa-
tients undergoing angiog-
raphy at non-PCI centres
(non-transferred) and pa-
tients undergoing angiogra-
phy at PCI centres (trans-
ferred)
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majority (9.1%) underwent angiography at a non-PCI
centre and 1.6% were directly transferred to a PCI cen-
tre for angiography. One-quarter of patients (27.0%)
underwent angiography at a non-PCI centre and were
later referred for PCI and 17.3% of patients were di-
rectly transferred to a PCI centre for angiography with
subsequent PCI.
Assuming patients would receive similar treatment
as observed in this registry, adoption of same-day
transfer to a PCI centre would increase transfers to
PCI centres of ESC-HR patients who undergo PCI
(44.3%). However, 36.2% of the ESC-HR patients
would be transferred to a PCI centre, but would be
medically treated and not undergo PCI. Patients who
would undergo CABG, but would otherwise be await-
ing surgery at a non-PCI centre (9.1%), may need
to be transferred back from the PCI centre to their
referring non-PCI centre to await surgery.
Discussion
In this registry of NSTE-ACS patients presenting at 23
non-PCI centres in the Netherlands, we found that the
majority of patients (55.8%) were classified as ESC-HR,
mostly based on elevated hs-cTn levels. Our findings
highlight that angiography of ESC-HR NSTE-ACS pa-
tients at non-PCI centres is still common (51.4%) and
same-day transfer to a PCI centre only occurs in one-
quarter of the ESC-HR patients, despite guideline rec-
ommendations. The revascularisation rate in ESC-HR
patients was 54.9%. Assuming patients would receive
similar treatment as observed in this registry, adopting
same-day transfer of ESC-HR NSTE-ACS patients pre-
senting at non-PCI centres would lead to an increase
of transfers of patient who undergo PCI. However, this
would also result in at least an equal number of trans-
fers of NSTE-ACS patients treated with medical ther-
apy alone.
The optimal timing of angiography and revascu-
larisation in NSTE-ACS has been extensively studied.
Since NSTE-ACS is a heterogeneous condition, the
expected benefit from early angiography depends
greatly on the severity of the symptoms and the pa-
tient’s risk profile. Therefore, timing of angiography is
based on risk stratification [1]. The recommendation
of same-day transfer aims to minimize the delay of
angiography (and revascularisation) in ESC-HR NSTE-
ACS patients. The 2015 guidelines put more emphasis
on same-day transfer of ESC-HR patients to a PCI-
centre, compared with earlier guidelines [1]. However,
both the 2011 and 2015 ESC NSTE-ACS guidelines are
largely based on the same studies [1, 3, 7, 10–13]. In
addition, two more studies were added to support
the 2015 guidelines [14, 15]. Although various studies
cited by the guidelines could not prove a benefit on
hard clinical endpoints with an early invasive strat-
egy (<24h), early angiography did reduce recurrent
ischaemia and shorten length of hospitalisation [13].
Our findings show that among non-transferred and
transferred ESC-HR patients, patients who were di-
rectly transferred to a PCI centre had higher rates
of immediate angiography (<2h) and revascularisa-
tion. Additionally, they were less often discussed by
a Heart Team compared with non-transferred ESC-
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Fig. 4 The current situation (left bar) and possible logis-
tical consequences of adopting same-day transfer to un-
dergo angiography at a PCI centre, as recommended by the
2015 NSTE-ACS ESC guidelines (right bar) (PCI percutaneous
coronary intervention, CABG coronary artery bypass graft-
ing, NSTE-ACS non-ST-elevation acute coronary syndrome,
ESC European Society of Cardiology)
HR patients. This may indicate that the attending
physician at the non-PCI centre used clinical assess-
ment, beyond ESC risk stratification, to refer some
ESC-HR patients for immediate angiography (possi-
bly followed by PCI) at a PCI centre and considered
other ESC-HR patients for angiography at a non-PCI
centre. Please note, non-transferred patients were sig-
nificantly older than transferred patients.
Based on the treatment patterns in our registry and
assuming similar treatment, 44.3% of ESC-HR patients
underwent PCI. If non-selective same-day transfer of
ESC-HR patients were to be adopted, there would be
an additional 27% of transfers to a PCI centre of pa-
tients who undergo PCI. On the other hand, 36.2% of
ESC-HR patients weremedically treated andmay have
a similar benefit of receiving optimal medical therapy
either at a non-PCI centre or a PCI centre. It raises
the question whether the potential pros of same-day
transfer outweigh the cons.
We believe the ideal timing (and location) of an-
giography in ESC-HR NSTE-ACS patients, needs to
be determined in a randomised trial that involves hs-
cTn assays, radial artery access, drug-eluting stents,
and novel P2Y12 inhibitors. For now, identifying the
NSTE-ACS patients who might benefit from early an-
giography and same-day transfer remains important.
A registry of 1,500 ESC-HR NSTE-ACS patients with
elevated hs-cTn levels without additional risk factors
admitted to German chest pain units, showed similar
rates of death, MI, or stroke at 4 months if patients
were treated with either medical therapy, PCI <24h, or
PCI >24h [16]. In the same study ESC-HR NSTE-ACS
patients who were at a higher risk (e.g. GRACE score
>140), PCI was associated with improved outcomes
compared with conservative treatment. Although
these results are merely hypothesis-generating, it sug-
gests research should focus on selecting the right
patients for same-day transfer, rather than non-se-
lectively adopting same-day transfer of patients with
elevated hs-cTn levels.
Currently, the attending physician at a non-PCI
centre triages patients who present with chest pain
suspected for NSTE-ACS. Several studies were con-
ducted to evaluate pre-hospital triage of patients with
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suspected NSTE-ACS [17, 18]. Point-of-care troponin
T testing by paramedics appears to be feasible [19].
In the NONSTEMI trial, pre-hospital troponin testing
was used to diagnose NSTE-ACS, whether immediate
or delayed angiography after point-of-care troponin
testing benefits outcomes remains to be determined
[18]. The FamouS Triage study used the modified
HEART score including point-of-care hs-cTn testing
in the pre-hospital setting. Patients with a modi-
fied HEART score of 0–3 did not develop any events
during follow-up and could be safely ruled-out for
MI by ambulance personnel [20]. The role of com-
puterised tomography (CT) coronary angiography in
NSTE-ACS patients will be further determined in the
RAPID-CTCA study, which compares early CT coro-
nary angiography with standard care with invasive
angiography in 2,500 patients with suspected NSTE-
ACS and elevated hs-cTn levels [21]. The first results
are expected in 2019.
Strengths & limitations
This study presents observational data from a se-
lection of non-PCI centres and offers a perspective
of NSTE-ACS care in the Netherlands. There are
some limitations. First, 23 non-PCI centres voluntar-
ily recorded data, therefore, these finding should be
generalised with caution. Second, the design of this
study was concise and with a modest dataset. We did
not record the process of clinical decision-making for
angiography at a PCI or a non-PCI centre. Third, we
could not include the whole study population for all
analyses due to missing data. Fourth, we could not
include discharge medication, mortality, or clinical
follow-up and cannot comment on clinical outcomes
of same-day-transfer based on these data.
Conclusion
In this registry of NSTE-ACS patients at non-PCI cen-
tres, most ESC-HR patients underwent angiography at
a non-PCI centre and same-day transfer occurred in
one-quarter of the ESC-HR patients, despite guideline
recommendations. Non-selective adoption of same-
day transfer to a PCI centre would increase the num-
ber of transfers of ESC-HR patients who undergo PCI,
however, equally increases the number of transfers of
ESC-HR patients who are medically treated. A ran-
domised trial in a contemporary setting is warranted
to determine the benefit of early angiography (and
same-day transfer) in NSTE-ACS patients with ele-
vated hs-cTn levels.
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